oncology

If the researchers are right, screening all women starting at 40 yields a lot of false diagnoses—without any clear benefit.

READ MORE >>

SHARE HIGHLIGHT

0 CHARACTERS SELECTED

TWEET THIS

POST TO TUMBLR